Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2025-12-29 @ 8:15 PM
Study NCT ID:
NCT00274456
Status:
COMPLETED
Last Update Posted:
2019-11-21
First Post:
2006-01-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2008-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-10
First Submit QC Date:
None
Study First Post Date:
2006-01-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-02-07
Results First Submit QC Date:
None
Results First Post Date:
2013-07-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-07
Last Update Post Date:
2019-11-21
Last Update Post Date Type:
ACTUAL